MedPath
NMPA Approval

Rivaroxaban Tablets

国药准字H20249407

November 15, 2024

Drug Information

利伐沙班片

片剂

20mg

化学药品

November 15, 2024

Company Information

Applicant Company

江西省宜春市奉新县江西奉新高新技术产业园区

Manufacturing Company

浙江省新昌县羽林街道新昌大道东路800号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利伐沙班片 - NMPA 批准文号 | MedPath